Literature DB >> 17122118

Control of filtering bleb structure through tissue bioengineering: An animal model.

Henry Shen-Lih Chen1, Robert Ritch, Theodore Krupin, Wei-Cherng Hsu.   

Abstract

PURPOSE: To devise a means of providing controlled resistance between the anterior chamber and the subconjunctival space after trabeculectomy by implantation of a biodegradable, porous collagen matrix.
METHODS: Matrices were implanted in the right eyes of 17 rabbits after trabeculectomy, while left eyes served as surgical controls. The scleral flap was sutured loosely, and the implant provided pressure on the scleral flap to reduce overfiltration. Trabeculectomy in the control eyes was performed with tight sutures using standard methodology. Intraocular pressure (IOP) was measured before surgery and on days 3, 7, 14, 21, and 28 after surgery. Masson trichrome and alpha-smooth muscle actin stains were used for histologic study of the filtering blebs.
RESULTS: The initial postoperative IOP reduction was approximately equal, at 14% to 16%, for both groups. In the implanted group, the IOP continued to decrease to 55% below baseline at day 28 as the implant gradually degraded. In the control group, IOP had returned to the preoperative level by day 21. Histologic examination with Masson trichrome and alpha-smooth muscle actin stains showed a prominent bleb in the implanted group compared with scar formation and limited bleb formation in the control group.
CONCLUSIONS: Implantation of a biodegradable, porous collagen matrix in the subconjunctival space offers the potential for a new means of avoiding early scar formation and maintaining long-term IOP control by creating a loosely structured filtering bleb.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122118     DOI: 10.1167/iovs.06-0378

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  Capsule excision and Ologen implantation for revision after glaucoma drainage device surgery.

Authors:  André Rosentreter; Anne C Mellein; Walter W Konen; Thomas S Dietlein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-20       Impact factor: 3.117

2.  Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.

Authors:  S Cillino; F Di Pace; G Cillino; A Casuccio
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

3.  Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil.

Authors:  Shivali A Menda; Eugene A Lowry; Travis C Porco; Robert L Stamper; Michel R Rubin; Ying Han
Journal:  Int Ophthalmol       Date:  2014-06-12       Impact factor: 2.031

4.  Preparation and properties of a drug release membrane of mitomycin C with N-succinyl-hydroxyethyl chitosan.

Authors:  Minyu Li; Baoqin Han; Wanshun Liu
Journal:  J Mater Sci Mater Med       Date:  2011-11-18       Impact factor: 3.896

5.  Trabeculectomy with Ologen implant versus mitomycin C in congenital glaucoma secondary to Sturge Weber Syndrome.

Authors:  Thanaa Helmy Mohamed; Abdelrahman Gaber Salman; Riham Fawzy Elshinawy
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

6.  Seprafilm as a new antifibrotic agent following trabeculectomy in rabbit eyes.

Authors:  Naoshi Tsurumaru; Mikki Arai; Kenichi Teruya; Jun Sueda; Ryoji Yamakawa
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

7.  Tissue bioengineering for surgical bleb defects: an animal study.

Authors:  Wei-Cherng Hsu; Robert Ritch; Theodore Krupin; Henry Shen-Lih Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-12       Impact factor: 3.117

8.  A new manner of reporting pressure results after glaucoma surgery.

Authors:  Constantin-Dan Bordeianu; Cristina-Eugenia Ticu
Journal:  Clin Ophthalmol       Date:  2011-12-30

9.  Biodegradable PTLGA Terpolymers versus Collagen Implants Used as an Adjuvant in Trabeculectomy in Rabbit Eye.

Authors:  Weiran Niu; Guanglin Shen; Yuanzhi Yuan; Xiaoping Ma; Suming Li; Jingzhao Wang; Zhongyong Fan; Lan Liao
Journal:  J Ophthalmol       Date:  2015-11-30       Impact factor: 1.909

Review 10.  Device-modified trabeculectomy for glaucoma.

Authors:  Xue Wang; Rabeea Khan; Anne Coleman
Journal:  Cochrane Database Syst Rev       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.